Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Officials Promise More "Swift, Aggressive" Actions, Outline Priorities

This article was originally published in The Tan Sheet

Executive Summary

FDA officials warn the agency will take increased "swift, aggressive" enforcement action in the next year, including more warning letters, seizures and injunctions, as it hones its risk-based enforcement approach

You may also be interested in...



Congress Emphasizes Strings As FDA Asks For Greater Budget Purse

FDA Commissioner Margaret Hamburg's testimony before congressional appropriations subcommittees inspired a sense of déjà vu even though she was testifying on the agency's budget for the first time since assuming the post nearly 10 months ago

Congress Emphasizes Strings As FDA Asks For Greater Budget Purse

FDA Commissioner Margaret Hamburg's testimony before congressional appropriations subcommittees inspired a sense of déjà vu even though she was testifying on the agency's budget for the first time since assuming the post nearly 10 months ago

Congress Emphasizes Strings As FDA Asks For Greater Budget Purse

FDA Commissioner Margaret Hamburg's testimony before congressional appropriations subcommittees inspired a sense of déjà vu even though she was testifying on the agency's budget for the first time since assuming the post nearly 10 months ago

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103434

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel